Bioventix PLC (LON:BVXP) Insider Bruce Hiscock Acquires 50 Shares

Bioventix PLC (LON:BVXPGet Rating) insider Bruce Hiscock acquired 50 shares of the stock in a transaction that occurred on Monday, November 21st. The shares were bought at an average cost of GBX 3,724 ($44.03) per share, with a total value of £1,862 ($2,201.73).

Bruce Hiscock also recently made the following trade(s):

  • On Wednesday, October 26th, Bruce Hiscock sold 204 shares of Bioventix stock. The stock was sold at an average price of GBX 3,341 ($39.51), for a total transaction of £6,815.64 ($8,059.17).

Bioventix Price Performance

LON:BVXP opened at GBX 3,650 ($43.16) on Wednesday. The stock has a market cap of £190.14 million and a PE ratio of 2,500.00. The business’s fifty day moving average is GBX 3,396.55 and its 200 day moving average is GBX 3,447.22.

Bioventix Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, November 18th. Investors of record on Thursday, November 3rd were given a dividend of GBX 100 ($1.18) per share. The ex-dividend date of this dividend was Thursday, November 3rd. This represents a dividend yield of 2.99%. This is a boost from Bioventix’s previous dividend of $52.00. Bioventix’s dividend payout ratio (DPR) is presently 8,630.14%.

Bioventix Company Profile

(Get Rating)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.